Cargando…
Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis
IMPORTANCE: Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease. Several studies have reported outcomes of Janus kinase (JAK) inhibitors for treating AA, but limited evidence has emerged. OBJECTIVE: To evaluate the effectiveness and safety associated with JAK inhibitors for A...
Autores principales: | Liu, Ming, Gao, Ya, Yuan, Yuan, Yang, Kelu, Shen, Caiyi, Wang, Jiancheng, Tian, Jinhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300710/ https://www.ncbi.nlm.nih.gov/pubmed/37368402 http://dx.doi.org/10.1001/jamanetworkopen.2023.20351 |
Ejemplares similares
-
Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018) -
Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015) -
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023) -
Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
por: SEDEH, Farnam Barati, et al.
Publicado: (2023) -
At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
por: Yale, Katerina, et al.
Publicado: (2020)